Many patients who are unable to eat require long-term nutritional support; hence the patients are provided nutrition with help of feeding tubes. Premature infants to elderly patients who are survivors of strokes, to people suffering from chronic conditions including cancer or head trauma require these enteral feeding formula as their life line support. As enteral feeding formulas are rich in protein, fiber and calories, these provide the patient proper nutrition for their survival. Owing to rise in number of chronic disease patients, rapid aging population and surging prevalence of preterm birth; the market is projected to grow during the forecast period. Escalating demand for home based treatment and services for elderly patients are another driving factor for enteral feeding formula market.
The enteral feeding formula market has been broadly studied based on numerous differentiating parameters to provide a comprehensive overview. The market has been categorized on basis of product type, therapeutic area and geography. By therapeutic area, the market has been divided as Oncology, Gastroenterology, Neurology and few more. On basis of geography, the market has been fragmented into Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW).
Americas is the leading region for enteral feeding formula market. Rising geriatric population and growing chronic disease patients in this region had elevated the growth of the market. Europe followed by APAC is other dominant region for the market. High consumption of tobacco products causing oral cancer and rapidly increasing aging population suffering from paralysis are the key drivers for growth of the market in APAC.
Sample Companies Profiled in this Report are:
- Abbott Laboratories (U.S.)
- Danone S.A. (France)
- Nestle S.A. (Switzerland)
- Fresenius Kabi AG (Germany)
- Mead Johnson Nutrition (U.S.)
These companies with innovative product launches and large investment in R&D department have acquired global market shares.
1. Enteral Feeding Formula – Market Overview
2. Executive Summary
3. Enteral Feeding Formula - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis
4. Enteral Feeding Formula - Market Forces
4.1.1. Rising prevalence of chronic diseases
4.1.2. Increasing need for home healthcare
4.1.3. Aging population
4.1.4. Preferred clinical nutrition
4.2. Constraints & Challenges
4.2.1. High R&D Expenditures
4.2.2. Stringent Regulations
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Customers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Enteral Feeding Formula Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Enteral Feeding Formula Market, By Product Type
6.1. Standard formula
6.2. Disease specific formulas
7. Enteral Feeding Formula Market, By Therapeutic Area
7.4. Critical care
8. Enteral Feeding Formula Market - By Geography
8.2.5. Rest Of Americas
8.3.5. Rest of Europe
8.4. Asia Pacific
8.4.4. Rest of Asia Pacific
8.5.1. Middle East
9. Market Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions and Joint Ventures
9.4. Supply - Contract
10. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
10.1. Abbott Laboratories
10.2. Nestle S.A.
10.4. Fresenius Kabi
10.5. Mead Johnson Nutrition Company
10.6. B.Braun Melsungen AG
10.7. Victus Inc.
10.8. Meiji Holdings Co., Ltd.
10.9. Global Health Product Inc.
10.10. Merck & Co., Inc.
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights